• Home
  • NEW DAY MEDICINE
  • 2 (88) 2026
  • 52 -2 (88) 2026 - Agababyan L.R., Rabbimova N.O‘. - OPTIMIZING THE MANAGEMENT STRATEGY FOR PREGNANT WOMEN WITH CERVICAL PATHOLOGY: THE ROLE OF THE VAGINAL MICROBIOTA

52 -2 (88) 2026 - Agababyan L.R., Rabbimova N.O‘. - OPTIMIZING THE MANAGEMENT STRATEGY FOR PREGNANT WOMEN WITH CERVICAL PATHOLOGY: THE ROLE OF THE VAGINAL MICROBIOTA

OPTIMIZING THE MANAGEMENT STRATEGY FOR PREGNANT WOMEN WITH CERVICAL PATHOLOGY: THE ROLE OF THE VAGINAL MICROBIOTA

Agababyan L.R. - Samarkand State Medical University

Rabbimova N.O‘. - Samarkand State Medical University

Resume

The relevance of this issue is driven by the increasing incidence of sexually transmitted infections and the consequent rise in benign background lesions, precancerous conditions, and malignant diseases of the cervix. According to the World Health Organization, cervical cancer is the fourth most common cancer among women worldwide; an estimated 604,000 new cases and 342,000 deaths were recorded in 2020.

Keywords: pregnancy, cervix, colposcopy, Pap test, liquid-based cytology, Femoflor-16, vaginal microbiota, bacterial vaginosis, PPROM, preterm birth, glycyrrhizic acid, cervical polyp.

First page

263

Last page

266

For citation:Agababyan L.R., Rabbimova N.O‘. - OPTIMIZING THE MANAGEMENT STRATEGY FOR PREGNANT WOMEN WITH CERVICAL PATHOLOGY: THE ROLE OF THE VAGINAL MICROBIOTA//New Day in Medicine 2(88)2026 263-266 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. American College of Obstetricians and Gynecologists. (2020, October 9). Updated guidelines for management of cervical cancer screening abnormalities (Practice Advisory). https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/10/updated-guidelines-for-management-of-cervical-cancer-screening-abnormalities
  2. Andzane, D., Zodzika, J., Jermakova, I., Senfelde, I., Utorova, M., & Rezeberga, D. (2025). Efficacy of topical treatment of low-risk cervical preinvasive lesions with glycyrrhizinic acid. Journal of Clinical Medicine, 2025;14(1):136. https://doi.org/10.3390/jcm14010136
  3. Centers for Disease Control and Prevention. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 2021;70(4):1-187. https://doi.org/10.15585/mmwr.rr7004a1
  4. DNA-Technology LLC. (n.d.). Femoflor® 16 REAL-TIME PCR detection kit (product information). Retrieved January 6, 2026, from https://dna-technology.com/Products/Human/REAL-TIME _PCR_Detection_Kits/Femoflor_16
  5. Feduniw S., Zeber-Lubecka, N., Kulecka, M., Ambroziak, A., Kukwa, W., & Paziewska, A. (2025). Does the vaginal microbiota influence the incidence of the preterm premature rupture of membranes? Journal of Clinical Medicine, 2025;14(18):65-77. https://doi.org/10.3390/jcm14186577
  6. GOV.UK. (2025, July 9). Cervical screening: programme and colposcopy management - management of cases relating to pregnancy, menopause, contraception and hysterectomy. https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management/4-management-of-cases-relating-to-pregnancy-menopause-contraception-and-hysterectomy
  7. Hirayama, E., Ebina, Y., Kato, K., Akabane-Nakagawa, K., Okuyama, K. (2022). Cervical polyps in early pregnancy are a risk factor for late abortion and spontaneous preterm birth: A retrospective cohort study. International Journal of Gynecology Obstetrics, 2022;156(1):64-70. https://doi.org/10.1002/ijgo.13608
  8. International Agency for Research on Cancer. (2022). Cervical cancer screening (IARC Handbooks of Cancer Prevention, Vol. 18). International Agency for Research on Cancer. https://publications.iarc.fr/586
  9. McIntyre-Seltman, K., Lesnock, J. L. (2008). Cervical cancer screening in pregnancy. Obstetrics and Gynecology Clinics of North America, 35(4), 645-658.
  10. Origoni M., Salvatore, S., Perino, A., Cucinella, G., Candiani, M. (2014). Cervical intraepithelial neoplasia (CIN) in pregnancy: The state of the art. European Review for Medical and Pharmacological Sciences, 2014;18:851-860.
  11. Perkins R. B., Guido R. S., Castle, P. E., et al. (2020). 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease, 2020;24(2):102-131. https://pmc.ncbi.nlm.nih.gov/articles/PMC7147428/
  12. Royal College of Obstetricians and Gynaecologists. (2025). Cervical screening, colposcopy and pregnancy (Patient information leaflet). https://www-preview.rcog.org.uk/media/xrief0ta/pi_cervical-smears-in-pregnancy_2025-pc.pdf
  13. World Health Organization. (2021). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (2nd ed.). World Health Organization. https://www.who.int/publications/i/item/9789240030824

    file

    download